Assessing the effect of Adjunctive probiotics therapy for the treatment of primary hypertension in children and adolescents: A randomized, double- blind, placebo- controlled trial
Phase 3
Recruiting
- Conditions
- Essential (primary) hypertension.Essential (primary) hypertension
- Registration Number
- IRCT20200608047689N3
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Essential high blood pressure I and II
Age range between 7-18 years
Exclusion Criteria
Active infection
Known organ damage
Use of probiotics in the 3 months prior to the study
Previous history of sensitivity to probiotics
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method